Growth Metrics

QuidelOrtho (QDEL) EBIAT (2021 - 2025)

QuidelOrtho's EBIAT history spans 5 years, with the latest figure at -$130.7 million for Q4 2025.

  • On a quarterly basis, EBIAT rose 26.74% to -$130.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 billion, a 44.84% increase, with the full-year FY2025 number at -$1.1 billion, up 44.84% from a year prior.
  • EBIAT hit -$130.7 million in Q4 2025 for QuidelOrtho, up from -$733.0 million in the prior quarter.
  • Over the last five years, EBIAT for QDEL hit a ceiling of $479.9 million in Q2 2022 and a floor of -$1.7 billion in Q1 2024.
  • Historically, EBIAT has averaged -$155.9 million across 5 years, with a median of -$16.3 million in 2023.
  • Biggest five-year swings in EBIAT: skyrocketed 232.98% in 2022 and later plummeted 3595.9% in 2024.
  • Tracing QDEL's EBIAT over 5 years: stood at $215.7 million in 2021, then crashed by 91.1% to $19.2 million in 2022, then plummeted by 2852.6% to -$528.5 million in 2023, then surged by 66.24% to -$178.4 million in 2024, then rose by 26.74% to -$130.7 million in 2025.
  • Business Quant data shows EBIAT for QDEL at -$130.7 million in Q4 2025, -$733.0 million in Q3 2025, and -$255.4 million in Q2 2025.